Prescription drug costs are a hot political issue, not as much because of the share of the U.S. health care dollar they consume but because…
Alnylam CEO John Maraganore aims to compete with what is expected to be a blockbuster hemophilia drug from Roche. A n experimental hemophilia drug developed…
According to the CDC, opioid prescriptions are on the decline. The number of prescriptions for opioids written by health care providers declined between 2012 and…